These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17397850)

  • 1. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients.
    Rodríguez M; Ringstad L; Schäfer P; Just S; Hofer HW; Malmsten M; Siegel G
    Atherosclerosis; 2007 Jun; 192(2):438-44. PubMed ID: 17397850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginkgo biloba (EGb 761) in arteriosclerosis prophylaxis.
    Siegel G; Schäfer P; Winkler K; Malmsten M
    Wien Med Wochenschr; 2007; 157(13-14):288-94. PubMed ID: 17704974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of arteriosclerotic nanoplaque formation and size by n-3 fatty acids in patients after valvular defect operation.
    Koppe C; Rodríguez M; Winkler K; Pietzsch J; Neumann K; Hiemann NE; Hetzer R; Malmsten M; Siegel G
    Forsch Komplementmed; 2009 Aug; 16(4):237-45. PubMed ID: 19729934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of garlic on arteriosclerotic nanoplaque formation and size.
    Siegel G; Malmsten M; Pietzsch J; Schmidt A; Buddecke E; Michel F; Ploch M; Schneider W
    Phytomedicine; 2004 Jan; 11(1):24-35. PubMed ID: 14971718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anionic biopolyelectrolytes of the syndecan/perlecan superfamily: physicochemical properties and medical significance.
    Siegel G; Malmsten M; Ermilov E
    Adv Colloid Interface Sci; 2014 Mar; 205():275-318. PubMed ID: 24534475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of arteriosclerotic nanoplaque formation and size by fluvastatin in a receptor-based biosensor model.
    Siegel G; Abletshauser C; Malmsten M; Schmidt A; Winkler K
    Cardiovasc Res; 2003 Jun; 58(3):696-705. PubMed ID: 12798444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosensing of arteriosclerotic nanoplaque formation and interaction with an HMG-CoA reductase inhibitor.
    Abletshauser C; Klüssendorf D; Schmidt A; Winkler K; März W; Buddecke E; Malmsten M; Siegel G
    Acta Physiol Scand; 2002 Oct; 176(2):131-45. PubMed ID: 12354173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of an HMG-CoA reductase inhibitor on arteriosclerotic nanoplaque formation and size in a biosensor model.
    Siegel G; Abletshauser C; Malmsten M; Klüssendorf D
    Biosens Bioelectron; 2003 May; 18(5-6):635-47. PubMed ID: 12706573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of arteriosclerotic plaque development by garlic].
    Siegel G; Michel F; Ploch M; Rodríguez M; Malmsten M
    Wien Med Wochenschr; 2004 Nov; 154(21-22):515-22. PubMed ID: 15638070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein binding to anionic biopolyelectrolytes and the effect of glucose on nanoplaque formation in arteriosclerosis and Alzheimer's disease.
    Siegel G; Mockenhaupt FHME; Behnke AL; Ermilov E; Winkler K; Pries AR; Malmsten M; Hetzer R; Saunders R; Lindman B
    Adv Colloid Interface Sci; 2016 Jun; 232():25-35. PubMed ID: 26969281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A receptor-based biosensor for lipoprotein docking at the endothelial surface and vascular matrix.
    Siegel G; Malmsten M; Klüssendorf D; Michel F
    Biosens Bioelectron; 2001 Dec; 16(9-12):895-904. PubMed ID: 11679268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgo biloba extract attenuates oxLDL-induced oxidative functional damages in endothelial cells.
    Ou HC; Lee WJ; Lee IT; Chiu TH; Tsai KL; Lin CY; Sheu WH
    J Appl Physiol (1985); 2009 May; 106(5):1674-85. PubMed ID: 19228986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba, inflammation and lipoprotein(a).
    Lippi G; Targher G; Guidi GC
    Atherosclerosis; 2007 Dec; 195(2):417-8; author reply 419-22. PubMed ID: 17572429
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined lowering of low grade systemic inflammation and insulin resistance in metabolic syndrome patients treated with Ginkgo biloba.
    Siegel G; Ermilov E; Knes O; Rodríguez M
    Atherosclerosis; 2014 Dec; 237(2):584-8. PubMed ID: 25463092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells.
    Tsai KL; Chang YL; Huang PH; Cheng YH; Liu DH; Chen HY; Kao CL
    J Vasc Surg; 2016 Jan; 63(1):204-15.e1. PubMed ID: 25080882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J; Kieser M; Hölscher U
    Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgo biloba extract attenuates oxLDL-induced endothelial dysfunction via an AMPK-dependent mechanism.
    Ou HC; Hsieh YL; Yang NC; Tsai KL; Chen KL; Tsai CS; Chen IJ; Wu BT; Lee SD
    J Appl Physiol (1985); 2013 Jan; 114(2):274-85. PubMed ID: 23195633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia.
    Razavi SM; Gholamin S; Eskandari A; Mohsenian N; Ghorbanihaghjo A; Delazar A; Rashtchizadeh N; Keshtkar-Jahromi M; Argani H
    J Med Food; 2013 Mar; 16(3):255-8. PubMed ID: 23437789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two dosages of ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb. A randomised, double-blind, multicentric clinical trial.
    Schweizer J; Hautmann C
    Arzneimittelforschung; 1999 Nov; 49(11):900-4. PubMed ID: 10604042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.